E1 enzymes as therapeutic targets in cancer

SH Barghout, AD Schimmer, E Barker - Pharmacological reviews, 2021 - Elsevier
Post-translational modifications of cellular substrates with ubiquitin and ubiquitin-like
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …

Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer

L Li, J Kang, W Zhang, L Cai, S Wang, Y Liang… - …, 2019 - thelancet.com
Background The neddylation pathway is overactivated in human cancers. Inhibition of
neddylation pathway has emerged as an attractive anticancer strategy. The mechanisms …

Targeting neddylation as a novel approach to lung cancer treatment

Z Tian, J Li, R Ma, T Li, Z Sun… - … Journal of Oncology, 2023 - spandidos-publications.com
As a protein that resembles ubiquitin, neural precursor cell expressed developmentally
downregulated 8 (NEDD8) takes part in neddylation, which modifies substrates in a manner …

Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor

LY Wei, ZX Wu, Y Yang, M Zhao, XY Ma, JS Li… - Experimental cell …, 2020 - Elsevier
Pevonedistat is a potent, selective, first-in-class NEDD8 activating enzyme inhibitor. It is now
under multiple clinical trials that investigate its anticancer effect against solid tumors and …

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma

J Xian, S Wang, Y Jiang, L Li, L Cai… - Cancer Biology & …, 2021 - pmc.ncbi.nlm.nih.gov
Objective: The hyperactivated neddylation pathway plays an important role in tumorigenesis
and is emerging as a promising anticancer target. We aimed to study whether NEDD8 …

[图书][B] Biopolymers for medical applications

JM Ruso, PV Messina - 2017 - books.google.com
This book presents an experimental and computational account of the applications of
biopolymers in the field of medicine. Biopolymers are macromolecules produced by living …

[HTML][HTML] UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway: UBA3 promotes the occurrence and …

H Zhang, J Yang, Q Song, X Ding, F Sun… - Acta Biochimica et …, 2024 - ncbi.nlm.nih.gov
Intrahepatic cholangiocarcinoma (ICC) accounts for approximately 15% of primary liver
cancers, and the incidence rate has been increasing in recent years. Surgical resection is …

Molecular dynamics simulation and free energy calculation studies of Coagulin L as dipeptidyl peptidase-4 inhibitor

A Singh, A Mishra - Journal of Biomolecular Structure and …, 2022 - Taylor & Francis
Plant derived product can be used as other alternatives to currently used drugs for
controlling chronic diseases like D iabetes mellitus. The potential of Coagulin L (a …

[HTML][HTML] Molecular dynamics simulation on the low sensitivity of mutants of NEDD-8 activating enzyme for MLN4924 inhibitor as a cancer drug

B Rashidieh, M Valizadeh, V Assadollahi… - American journal of …, 2015 - ncbi.nlm.nih.gov
MLN4924 is an experimental cancer drug known as inhibitor of NEDD8-activating enzyme
(NAE). This anti-tumor candidate is a selective small-molecule inhibitor of NAE which is …

UBA3 is a potential diagnostic marker and regulates the proliferation and migration in intrahepatic cholangiocarcinama

H Zhang, J Yang, L Yang - 2023 - researchsquare.com
Background: Intrahepatic cholangiocarcinoma (ICC) accounts for about 15% of primary liver
cancer, and the incidence rate has been rising in recent years. Surgical resection is the best …